Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer

NCT00054184 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
DRUG: paclitaxel poliglumex

Sponsor

CTI BioPharma